Tumor Genomics Group is one of the largest biomedical research groups in Finland with 37 members, and focuses on human tumor susceptibility as well as somatic cancer genomics. The group is a leading member of the Academy of Finland’s Center of Excellence in Tumor Genetics Research and one of few in Europe that has succeeded in winning two consecutive ERC advanced grants (2011 and 2016).

Latest publications

RSS Feed

No results.

CoETG-video

@AaltonenLab

Congrats! twitter.com/NykterLab/stat…

Christmas has come early here at the @AaltonenLab, how about you? :) 🎄 🎅 🌨 https://t.co/49BEZqUaeC

#NewNProt: Using BasePlayer for variant analysis to discover potential causative #mutations in human coding and… twitter.com/i/web/status/1…

Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival biorxiv.org/content/early/…

@CoEinTG

”Siinä vaiheessa kun #syöpä on tautina voitettu, me olemme valmiita” – professori Lauri Aaltonen. Kasvaingenetiika… twitter.com/i/web/status/1…

Greetings from @SuomenAkatemia Annual Seminar of the Centres of Excellence aimed at promoting #networking between t… twitter.com/i/web/status/1…

Finally out! Introduction to our #ComputationalBiology research at @TampereUni & @CoEinTG, presented by prof. Nykte… twitter.com/i/web/status/1…

Very useful reading also for the @CoEinTG members twitter.com/HerculesOvCa/s…